Please login to order a test.
Chlamydia/Gonococcus/Genital Mycoplasma Profile, NAA, Urine
Detect Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma genitalium, Mycoplasma hominis, Ureaplasma spp
This test was developed, and its performance characteristics determined, by LabCorp. It has not been cleared or approved by the US Food and Drug Administration (FDA). The FDA has determined that such clearance or approval is not necessary.
Nucleic acid amplification (NAA)
First-void urine in Aptima® urine transport
2 mL aliquot of a 20 to 30 mL urine collection
Urine specimen: The patient should not have urinated for at least one hour prior to specimen collection. Direct patient to provide a first-catch urine (approximately 20 mL to 30 mL of the initial urine stream) into a urine collection container free of any preservatives. Collection of larger volumes of urine may result in specimen dilution that may reduce test sensitivity; lesser volumes may not adequately rinse organisms into the specimen. Female patients should not cleanse the labial area prior to providing the specimen. Add urine to the Aptima® Combo 2 urine collection device. The final volume must be between the two black lines on the device (about 2 mL).
Causes for Rejection
|Order Code||Order Code Name||Order Loinc||Result Code||Result Code Name||UofM||Result LOINC|
|180051||Ct, Ng, Mycoplasmas NAA, Urine||180024||Mycoplasma genitalium NAA||69935-5|
|180051||Ct, Ng, Mycoplasmas NAA, Urine||180037||Mycoplasma hominis NAA||68546-1|
|180051||Ct, Ng, Mycoplasmas NAA, Urine||180038||Ureaplasma spp NAA||68547-9|
|180051||Ct, Ng, Mycoplasmas NAA, Urine||180044||Comment:||N/A|
|180051||Ct, Ng, Mycoplasmas NAA, Urine||180050||Chlamydia trachomatis, NAA||42931-6|
|180051||Ct, Ng, Mycoplasmas NAA, Urine||180052||Neisseria gonorrhoeae, NAA||60256-5|